[go: up one dir, main page]

AU2002256304A1 - Compositions for delivery of compounds to cells and methods of use - Google Patents

Compositions for delivery of compounds to cells and methods of use

Info

Publication number
AU2002256304A1
AU2002256304A1 AU2002256304A AU2002256304A AU2002256304A1 AU 2002256304 A1 AU2002256304 A1 AU 2002256304A1 AU 2002256304 A AU2002256304 A AU 2002256304A AU 2002256304 A AU2002256304 A AU 2002256304A AU 2002256304 A1 AU2002256304 A1 AU 2002256304A1
Authority
AU
Australia
Prior art keywords
delivery
compositions
cells
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002256304A
Inventor
Srilalitha Belur
Perry B. Hackett
Betsy T. Kren
Cheryle Linehan-Stieers
Scott R. MCIVOR
Clifford J. Steer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
LINEHAN STIEERS CHERYLE
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/861,014 external-priority patent/US20020115216A1/en
Application filed by LINEHAN STIEERS CHERYLE, University of Minnesota Twin Cities, University of Minnesota System filed Critical LINEHAN STIEERS CHERYLE
Publication of AU2002256304A1 publication Critical patent/AU2002256304A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2002256304A 2001-04-20 2002-04-22 Compositions for delivery of compounds to cells and methods of use Abandoned AU2002256304A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US28516701P 2001-04-20 2001-04-20
US28512101P 2001-04-20 2001-04-20
US60/285,167 2001-04-20
US60/285,121 2001-04-20
US09/861,014 US20020115216A1 (en) 2000-05-19 2001-05-19 Composition for delivery of compounds to cells
US09/861,014 2001-05-19
PCT/US2002/012607 WO2002086074A2 (en) 2001-04-20 2002-04-22 Compositions for delivery of compounds to cells and methods of use

Publications (1)

Publication Number Publication Date
AU2002256304A1 true AU2002256304A1 (en) 2002-11-05

Family

ID=27403505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002256304A Abandoned AU2002256304A1 (en) 2001-04-20 2002-04-22 Compositions for delivery of compounds to cells and methods of use

Country Status (2)

Country Link
AU (1) AU2002256304A1 (en)
WO (1) WO2002086074A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017210141A1 (en) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion to provide surfactant-containing fleets
DE102017210143A1 (en) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Viscoelastic, solid surfactant composition
KR102510197B1 (en) 2017-06-16 2023-03-15 헨켈 아게 운트 코. 카게아아 Viscoelastic solid surfactant composition with high surfactant content
DE102017223460A1 (en) 2017-12-20 2019-06-27 Henkel Ag & Co. Kgaa Viscose-elastic, high-surfactant, solid surfactant composition
DE102017223456A1 (en) 2017-12-20 2019-06-27 Henkel Ag & Co. Kgaa Viscoelastic, high solids surfactant composition
WO2018229036A1 (en) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Viscoelastic, solid-state surfactant composition having a high surfactant content
DE102018201830A1 (en) 2018-02-06 2019-08-08 Henkel Ag & Co. Kgaa Viscoelastic, solid surfactant composition
DE102018209002A1 (en) 2018-06-07 2019-12-12 Henkel Ag & Co. Kgaa Detergent composition with yield value
DE102018219413A1 (en) 2018-11-14 2020-05-14 Henkel Ag & Co. Kgaa Textile pretreatment composition containing a shaped body with a glucosamine derivative as a low-molecular gelling agent
DE102018219415A1 (en) 2018-11-14 2020-05-14 Henkel Ag & Co. Kgaa Textile pretreatment composition containing a shaped body with a low molecular weight gel former
DE102018221674A1 (en) 2018-12-13 2020-06-18 Henkel Ag & Co. Kgaa Device and method for producing a water-soluble casing and detergent or cleaning agent portions containing this water-soluble casing
DE102018221671A1 (en) 2018-12-13 2020-06-18 Henkel Ag & Co. Kgaa Device and method for producing a water-soluble casing and detergent or cleaning agent portions containing this water-soluble casing with viscoelastic, solid filler substance
CN110438162B (en) * 2019-08-22 2021-06-25 广州晶欣生物科技有限公司 Improved non-liposome transfection kit and application method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225121B1 (en) * 1992-09-14 2001-05-01 Institute Of Molecular Biology And Biotechnology/Forth Eukaryotic transposable element
KR20000076157A (en) * 1997-03-11 2000-12-26 리전츠 오브 더 유니버스티 오브 미네소타 Dna-based transposon system for the introduction of nucleic acid into dna of a cell
DE10120829A1 (en) * 2000-04-27 2001-12-20 Max Delbrueck Centrum Gene transfer method, useful in therapy, diagnosis and preparing transgenic animals, uses both components of the Sleeping Beauty transfer system

Also Published As

Publication number Publication date
WO2002086074A3 (en) 2003-07-17
WO2002086074A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
EP1576150A3 (en) Methods and compositions for increasing the efficacy of biologically-active ingredients
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003218759A1 (en) Stabilization of resorcinol derivatives in cosmetic compositions
AU2003257937A1 (en) Methods and compositions for treatment of dermal conditions
AU2003303513A1 (en) Tissue reactive compounds and compositions and uses thereof
AU2001273034A1 (en) Composition for delivery of hematopoietic growth factor
AU2003285526A1 (en) Use of polyethylene compositions
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
AU2001233081A1 (en) Composition for treatment of stress
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2002317374A1 (en) Storage of liquid compositions
AU2002256304A1 (en) Compositions for delivery of compounds to cells and methods of use
AU2003300692A1 (en) Stable formulations of ace inhibitors and methods for preparation thereof
AU2003247351A1 (en) Anti-acne compositions and methods of use
AU2002362118A1 (en) Compositions and methods for high sorption of skin materials and delivery of sulfur
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
AU2003205717A1 (en) New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
AU2001261732A1 (en) Composition for delivery of compounds to cells
AU2003233445A1 (en) Antimicrobial compositions and methods of use
AU2003287249A1 (en) Organic acid containing compositions and methods for use thereof
AU2003241103A1 (en) Compositions containing anti-hiv peptides and methods of use
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2002252387A1 (en) Novel anti-inflammatory compositions and methods of use
AU2003215264A1 (en) Compositions and methods for delivery of skin cosmeceuticals
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase